Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Makorin ring finger protein 8, pseudogene (MKRN8P; also known as LOC391033) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but nonfunctional; that is, it does not produce a functional protein product[1]. MKRN8P is not transcribed or translated into protein, and there is no evidence for any physiological or pathological function attributed to it[1][2]. Pseudogenes like MKRN8P are generally considered evolutionary relics; in contrast to protein-coding genes, they do not serve as therapeutic targets, receptors, enzymes, or biomarkers[2][3]. There are no known drug interactions, associated diseases, or described mechanisms of action for this pseudogene[1]. Key clarification: MKRN8P is a pseudogene and is not a valid therapeutic target; its inclusion in target lists is likely due to gene annotation artifacts and it should not be considered for receptor, enzyme, or drug target research[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Makorin ring finger protein 8, pseudogene (MKRN8P).